Novo Nordisk A/S
NVO
Company Profile
Business description
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Contact
Novo Alle 1
Bagsvaerd 2880
DNKT: +45 44448888
E: phak@novonordisk.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
66,015
Novo Nordisk A/S News & Analysis
stocks
Obesity drug stocks: Why it will be ‘exceptionally difficult’ to dethrone Eli Lilly and Novo Nordisk
The two biggest players in the market appear poised to dominate for years to come.
stocks
Obesity drug stocks: Where to invest now
Eli Lilly and Novo Nordisk have staged big rallies. Here’s how investors can approach this potentially huge opportunity.
stocks
Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?
‘Granolas’ stocks are profitable, diversified, cheap—and posting big returns.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 8,262.40 | 56.30 | 0.69% |
CAC 40 | 7,632.71 | 91.61 | -1.19% |
DAX 40 | 18,590.89 | 157.29 | -0.84% |
Dow JONES (US) | 40,211.72 | 210.82 | 0.53% |
FTSE 100 | 8,182.96 | 69.95 | -0.85% |
HKSE | 18,015.94 | 277.44 | -1.52% |
NASDAQ | 18,472.57 | 74.12 | 0.40% |
Nikkei 225 | 41,190.68 | 1,033.34 | -2.45% |
NZX 50 Index | 12,096.43 | 26.71 | -0.22% |
S&P 500 | 5,631.22 | 15.87 | 0.28% |
S&P/ASX 200 | 8,017.60 | 58.30 | 0.73% |
SSE Composite Index | 2,974.01 | 2.72 | 0.09% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
Cooper Energy Ltd COE | 0.22 | 0.01 | -4.44% |
Imugene Ltd IMU | 0.06 | 0.00 | -3.39% |
Zip Co Ltd ZIP | 1.58 | 0.12 | -7.08% |
Core Lithium Ltd CXO | 0.12 | 0.01 | 9.09% |
Mirvac Group MGR | 2.08 | 0.07 | 3.48% |
AMP Ltd AMP | 1.13 | 0.00 | 0.00% |
Red 5 Ltd RED | 0.42 | 0.01 | -1.18% |
Pantoro Ltd PNR | 0.09 | 0.00 | -2.11% |
Telstra Group Ltd TLS | 3.84 | 0.02 | 0.52% |